The KCSA Psychedelics Conference features live presentations and speakers who will address the various investment opportunities in psychedelic treatments for mental health disorders.

The agenda highlights companies representing research, drug development, patient care delivery, integrated technology solutions, and patient support services that are crucial components of the reemerging psychedelic industry.

Presenting companies include a variety of business models including drug developers, investment funds, care delivery treatment clinics, cGMP operators, and vertically integrated business models.

October 13th Agenda

9:45 AM ET

KCSA Opening Remarks

10:00 AM ET

Company Name Logo
Small Pharma Inc.

TSX-V: DMT
Peter Rands, CEO
Dr Carol Routledge, Chief Scientific and Medical Officer


10:30 AM ET

Company Name Logo
Awakn Life Sciences Corp.

OTCQB: AWKNF | NEO: AWKN
Anthony Tennyson, CEO


11:00 AM ET

Company Name Logo
HMNC Brain Health

Private Company
Benedikt von Braunmühl, CEO
Maximilian Döbler, Head of Operations


11:30 AM ET

Company Name Logo
Enveric Biosciences

NASDAQ: ENVB
Joseph Tucker, CEO


12:00 PM ET

Company Name Logo
Mind Cure Health Inc.

OTCQX: MCURF | CSE: MCUR
Kelsey Ramsden, President & CEO


12:30 PM ET

Company Name Logo
Field Trip Health Ltd.

NASDAQ: FTRP | TSX: FTRP
Joseph del Moral, Co-Founder & CEO


1:00 PM ET

Company Name Logo
Novamind Inc.

OTCQB: NVMDF | CSE: NM
Yaron Conforti, CEO, Director, Co-Founder


1:30 PM ET

Company Name Logo
BetterLife Pharma Inc.

OTCQB: BETRF | CSE: BETR
Ahmad Doroudian, CEO & Director


2:00 PM ET

Company Name Logo
MYND Life Sciences Inc.

Pink: MYNDF | CSE: MYND
Dr. Lyle Oberg, CEO

October 14th Agenda

 9:50 AM ET

KCSA Opening Remarks

10:00 AM ET

Company Name Logo
Mindset Pharma Inc.

OTCQB: MSSTF | CSE: MSET
James Lanthier, CEO


10:30 AM ET

Company Name Logo
PsyBio Therapeutics Corp.

OTCQB: PSYBF | TSX-V: PSYB
Evan Levine, Co-Founder, CEO and Director


11:00 AM ET

Company Name Logo
Psyched Wellness Ltd.

OTCQB: PSYCF | CSE: PSYC
Jeff Stevens, CEO


11:30 AM ET

Company Name Logo
Bright Minds Biosciences Inc.

OTCQB: BMBIF | CSE: DRUG
Ian McDonald, President & CEO
Josh Blacher, VP of Corporation Development


12:00 PM ET

Company Name Logo
Fireside Chat

Amy Emerson, CEO, MAPS Public Benefit Corp
Moderated by Tim Regan, SVP, KCSA Strategic Communications


12:30 PM ET

Company Name Logo
advisor shares
Lunch Panel – Investing in Psychedelics and CNS Treatments

Lindsay Hoover, Partner, JLS Fund
Dan Ahrens, PM of the Psychedelics ETF (NYSEArca: PSIL),
AdvisorShares Investments
Moderated by Tim Regan, SVP, KCSA Strategic Communications


1:00 PM ET

Company Name Logo
Cybin Inc.

NYSE American: CYBN | NEO: CYBN
Doug Drysdale, CEO


1:30 PM ET

Company Name Logo
Mydecine Innovations Group

Pink: MYCOF | NEO: MYCO
Joshua Bartch, CEO


2:00 PM ET

Company Name Logo
NeonMind Biosciences Inc.

OTCQB: NMDBF | CSE: NEON
Rob Tessarolo, President & CEO


2:30 PM ET

Company Name Logo
Numinus Wellness Inc.

TSX-V: NUMI
Payton Nyquvest, Founder & CEO


3:00 PM ET

Company Name Logo
Tryp Therapeutics Inc.

OTCQB: TRYPF | CSE: TRYP
Luke Hayes, CFO


3:30 PM ET

Company Name Logo
Wesana Health Holdings Inc.

OTCQB: WSNAF | CSE: WESA
Daniel Carcillo, CEO


4:00 PM ET

Company Name Logo
Filament Health Corp.

Pink: FLHLF | NEO: FH
Ben Lightburn, CEO